Mark Blostein

4.8k total citations
81 papers, 2.2k citations indexed

About

Mark Blostein is a scholar working on Hematology, Internal Medicine and Surgery. According to data from OpenAlex, Mark Blostein has authored 81 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 30 papers in Internal Medicine and 19 papers in Surgery. Recurrent topics in Mark Blostein's work include Venous Thromboembolism Diagnosis and Management (30 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers) and Atrial Fibrillation Management and Outcomes (15 papers). Mark Blostein is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (30 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers) and Atrial Fibrillation Management and Outcomes (15 papers). Mark Blostein collaborates with scholars based in Canada, United States and Australia. Mark Blostein's co-authors include Susan R. Kahn, Catherine A. Lemarié, Vicky Tagalakis, Michael Libman, Sandrine Laurance, Jessica Cuerquis, Barbara C. Furie, Bruce Furie, Brian Varnum and Jacques Galipeau and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.

In The Last Decade

Mark Blostein

80 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Blostein Canada 28 607 603 445 413 410 81 2.2k
Joseph J. Shatzel United States 28 552 0.9× 440 0.7× 829 1.9× 409 1.0× 283 0.7× 156 2.7k
Erwin Blessing Germany 32 1.1k 1.8× 936 1.6× 356 0.8× 1.5k 3.6× 593 1.4× 105 4.0k
Francesco Tonelli Italy 33 335 0.6× 491 0.8× 170 0.4× 1.5k 3.7× 690 1.7× 141 5.3k
Walter A. Wuillemin Switzerland 37 1.1k 1.7× 1.0k 1.7× 1.8k 4.0× 665 1.6× 881 2.1× 130 4.6k
T. Andrea United States 23 329 0.5× 923 1.5× 253 0.6× 653 1.6× 359 0.9× 94 2.1k
Dietrich C. Gulba Germany 28 1.8k 3.0× 689 1.1× 432 1.0× 894 2.2× 315 0.8× 103 3.3k
Antonio Ordinas Spain 35 629 1.0× 419 0.7× 2.1k 4.8× 552 1.3× 366 0.9× 173 3.6k
Jørgen Gram Denmark 27 589 1.0× 336 0.6× 761 1.7× 401 1.0× 135 0.3× 167 2.8k
Anne Angelillo‐Scherrer Switzerland 31 655 1.1× 558 0.9× 921 2.1× 457 1.1× 859 2.1× 115 3.4k
J. Vermylen Belgium 31 486 0.8× 305 0.5× 1.1k 2.4× 533 1.3× 172 0.4× 110 2.6k

Countries citing papers authored by Mark Blostein

Since Specialization
Citations

This map shows the geographic impact of Mark Blostein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Blostein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Blostein more than expected).

Fields of papers citing papers by Mark Blostein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Blostein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Blostein. The network helps show where Mark Blostein may publish in the future.

Co-authorship network of co-authors of Mark Blostein

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Blostein. A scholar is included among the top collaborators of Mark Blostein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Blostein. Mark Blostein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laurance, Sandrine, François Bertin, Lénaïck Gourhant, et al.. (2024). Extracellular RNA Induces Neutrophil Recruitment Via Toll‐Like Receptor 3 During Venous Thrombosis After Vascular Injury. Journal of the American Heart Association. 13(15). e034492–e034492.
2.
Lee, Amanda, Chu‐Shu Gu, Suresh Vedantham, et al.. (2021). Performance of two clinical scales to assess quality of life in patients with post-thrombotic syndrome. Journal of Vascular Surgery Venous and Lymphatic Disorders. 9(5). 1257–1265.e2. 5 indexed citations
3.
Kaur, Manraj, Donald M. Arnold, Nancy M. Heddle, et al.. (2021). Cost-effectiveness of eltrombopag vs intravenous immunoglobulin for the perioperative management of immune thrombocytopenia. Blood Advances. 6(3). 785–792. 9 indexed citations
4.
Kovacs, Michael J., Philip S. Wells, David R. Anderson, et al.. (2021). Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 373. n1205–n1205. 44 indexed citations
5.
Bertin, François, et al.. (2015). Growth arrest‐specific 6 regulates thrombin‐induced expression of vascular cell adhesion molecule‐1 through forkhead box O1 in endothelial cells. Journal of Thrombosis and Haemostasis. 13(12). 2260–2272. 12 indexed citations
6.
Douketis, Jim, Gang Wang, Noel Chan, et al.. (2015). Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure. Journal of Thrombosis and Haemostasis. 14(1). 89–97. 33 indexed citations
7.
Ibrahim, R.N., Beste Küçükyazicı, Vedat Verter, Michel Gendreau, & Mark Blostein. (2015). Designing Personalized Treatment: An Application to Anticoagulation Therapy. Production and Operations Management. 25(5). 902–918. 19 indexed citations
8.
Schulman, Sam, John A. Stewart, Anne McLeod, et al.. (2012). Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. Thrombosis and Haemostasis. 108(9). 493–498. 48 indexed citations
9.
Blostein, Mark, et al.. (2011). Elevated plasma gas6 levels are associated with venous thromboembolic disease. Journal of Thrombosis and Thrombolysis. 32(3). 272–278. 21 indexed citations
10.
Blostein, Mark, et al.. (2011). Delayed Immune-Mediated Thrombocytopenia After Re-exposure to Abciximab Therapy. Canadian Journal of Cardiology. 27(6). 869.e13–869.e14. 2 indexed citations
11.
Ageno, Walter, Mark Blostein, Sam Schulman, et al.. (2010). Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Thrombosis and Haemostasis. 104(7). 118–121. 28 indexed citations
12.
Crowther, Mark, Walter Ageno, David García, et al.. (2009). Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin. Annals of Internal Medicine. 150(5). 293–300. 98 indexed citations
13.
Ganopolsky, Jorge G., M. Ruhul Abid, William C. Aird, & Mark Blostein. (2008). GAS6‐induced signaling in human endothelial cells is mediated by FOXO1a. Journal of Thrombosis and Haemostasis. 6(10). 1804–1811. 18 indexed citations
14.
Tagalakis, Vicky, Hani Tamim, Mark Blostein, et al.. (2007). Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study. The Lancet Oncology. 8(5). 395–402. 55 indexed citations
15.
Tagalakis, Vicky, et al.. (2006). The effect of warfarin on the risk of prostate cancer. Journal of Clinical Oncology. 24(18_suppl). 14524–14524. 1 indexed citations
16.
Blostein, Mark, et al.. (2005). The role of γ-carboxylation in the anti-apoptotic function of gas6. Journal of Thrombosis and Haemostasis. 3(12). 2790–2797. 81 indexed citations
17.
Blostein, Mark, et al.. (2003). The Gla Domain of Factor IXa Binds to Factor VIIIa in the Tenase Complex. Journal of Biological Chemistry. 278(33). 31297–31302. 36 indexed citations
18.
Tagalakis, Vicky, Susan R. Kahn, Michael Libman, & Mark Blostein. (2002). The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. The American Journal of Medicine. 113(2). 146–151. 201 indexed citations
19.
Blostein, Mark, et al.. (2000). The Gla Domain of Human Prothrombin Has a Binding Site for Factor Va. Journal of Biological Chemistry. 275(48). 38120–38126. 37 indexed citations
20.
Freedman, Steven J., Mark Blostein, James Baleja, et al.. (1996). Identification of the Phospholipid Binding Site in the Vitamin K-dependent Blood Coagulation Protein Factor IX. Journal of Biological Chemistry. 271(27). 16227–16236. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph J. Shatzel Breakdown of academic impact, for papers by Erwin Blessing Breakdown of academic impact, for papers by Francesco Tonelli Breakdown of academic impact, for papers by Walter A. Wuillemin Breakdown of academic impact, for papers by T. Andrea Breakdown of academic impact, for papers by Dietrich C. Gulba Breakdown of academic impact, for papers by Antonio Ordinas Breakdown of academic impact, for papers by Jørgen Gram Breakdown of academic impact, for papers by Anne Angelillo‐Scherrer Breakdown of academic impact, for papers by J. Vermylen
Rankless by CCL
2026